Related Experiment Video
Updated: Jul 1, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.5K
Spatial profiling of human diffuse cutaneous leishmaniasis lesions reveals immunosuppressive microenvironments that
Paola Oliveira Lopes1, Carlos Henrique Fantecelle2, Bruna Amorim Barboza2
1Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil; Núcleo de Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Brazil.
The Journal of Investigative Dermatology
|November 29, 2025
Abstract
No abstract available in PubMed .
More Related Videos
11:36Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
22.5K
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
18.1K
Related Concept Videos
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...